• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic. Authors' reply.社论：在 COVID-19 大流行背景下，IBD 的患病率及其并发症不断增加。作者回复。
Aliment Pharmacol Ther. 2020 Jun;51(12):1442-1443. doi: 10.1111/apt.15769. Epub 2020 May 14.
2
Editorial: social distancing during the COVID-19 pandemic-IBD patients cannot stay at home forever. Authors' reply.社论：2019冠状病毒病大流行期间的社交距离——炎症性肠病患者不能永远居家。作者回复。
Aliment Pharmacol Ther. 2020 Aug;52(4):719-720. doi: 10.1111/apt.15937.
3
Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic.社论：在 COVID-19 大流行背景下，IBD（炎症性肠病）的患病率及其并发症不断增加。
Aliment Pharmacol Ther. 2020 Jun;51(12):1441-1442. doi: 10.1111/apt.15759. Epub 2020 May 14.
4
Prevention of COVID-19 in patients with IBD - Authors' reply.炎症性肠病患者中新型冠状病毒肺炎的预防——作者回复
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):640-641. doi: 10.1016/S2468-1253(20)30156-4.
5
Letter: IBD nurse-pivotal role in the time of the pandemic. Authors' reply.信件：炎症性肠病护士在疫情期间的关键作用。作者回复。
Aliment Pharmacol Ther. 2020 Aug;52(4):746-747. doi: 10.1111/apt.15954.
6
Emotional state should not be used to differentiate IBD from IBS - Authors' reply.不应使用情绪状态来区分炎症性肠病和肠易激综合征——作者回复。
Lancet Gastroenterol Hepatol. 2020 Aug;5(8):723-724. doi: 10.1016/S2468-1253(20)30199-0.
7
Editorial: social distancing during the COVID-19 pandemic - IBD patients cannot stay at home forever.社论：2019冠状病毒病大流行期间的社交距离——炎症性肠病患者不能永远居家
Aliment Pharmacol Ther. 2020 Aug;52(4):717-718. doi: 10.1111/apt.15874.
8
Reply to the Letter to the Editor: The Incidence and Outcomes of COVID-19 in Patients With IBD: A Rapid Review and Meta-Analysis.致编辑的信的回复：炎症性肠病患者中新冠病毒病的发病率和结局：快速综述与荟萃分析
Inflamm Bowel Dis. 2020 Sep 18;26(10):e127. doi: 10.1093/ibd/izaa172.
9
Protecting patients with IBD during the COVID-19 pandemic.在新冠疫情期间保护炎症性肠病患者。
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):639. doi: 10.1016/S2468-1253(20)30152-7. Epub 2020 May 20.
10
IBD in the Times of COVID-19.新冠疫情时代的炎症性肠病
Inflamm Bowel Dis. 2020 Jul 17;26(8):e92. doi: 10.1093/ibd/izaa132.

引用本文的文献

1
Impact of Mild COVID-19 History on Oral-Gut Microbiota and Serum Metabolomics in Adult Patients with Crohn's Disease: Potential Beneficial Effects.轻度新冠病史对成年克罗恩病患者口腔-肠道微生物群和血清代谢组学的影响：潜在益处
Biomedicines. 2024 Sep 14;12(9):2103. doi: 10.3390/biomedicines12092103.
2
COVID-19 and inflammatory bowel disease crosstalk: From emerging association to clinical proposal.COVID-19 与炎症性肠病的相互作用：从新出现的关联到临床建议。
J Med Virol. 2022 Dec;94(12):5640-5652. doi: 10.1002/jmv.28067. Epub 2022 Aug 24.
3
SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role.SARS-CoV-2 微生物失调相关疾病及可能的益生菌作用。
Biomed Pharmacother. 2021 Jan;133:110947. doi: 10.1016/j.biopha.2020.110947. Epub 2020 Nov 11.

本文引用的文献

1
Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic.社论：在 COVID-19 大流行背景下，IBD（炎症性肠病）的患病率及其并发症不断增加。
Aliment Pharmacol Ther. 2020 Jun;51(12):1441-1442. doi: 10.1111/apt.15759. Epub 2020 May 14.
2
Changing patterns in the epidemiology and outcomes of inflammatory bowel disease in the United Kingdom: 2000-2018.英国炎症性肠病的流行病学和结局变化模式：2000-2018 年。
Aliment Pharmacol Ther. 2020 May;51(10):922-934. doi: 10.1111/apt.15701. Epub 2020 Apr 1.
3
SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染导致新型冠状病毒肺炎（COVID-19）患者出现腹泻作为首发症状。
Gut. 2020 Jun;69(6):1143-1144. doi: 10.1136/gutjnl-2020-320891. Epub 2020 Mar 5.
4
Influenza A (H1N1)v infection in patients with inflammatory bowel disease: a case series.甲型H1N1流感病毒感染炎症性肠病患者：病例系列
Aliment Pharmacol Ther. 2011 Feb;33(4):499-500. doi: 10.1111/j.1365-2036.2010.04558.x.

社论：在 COVID-19 大流行背景下，IBD 的患病率及其并发症不断增加。作者回复。

Editorial: increasing IBD prevalence and its complications in the context of the COVID-19 pandemic. Authors' reply.

机构信息

Department of Gastroenterology, Sandwell and West Birmingham Hospitals NHS Trust, West Bromwich, UK.

IAHR, University of Birmingham, Birmingham, UK.

出版信息

Aliment Pharmacol Ther. 2020 Jun;51(12):1442-1443. doi: 10.1111/apt.15769. Epub 2020 May 14.

DOI:10.1111/apt.15769
PMID:32406090
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7272960/
Abstract

This article is linked to King et al and Benson‐Pope and Greary papers. To view these articles, visit https://doi.org/10.1111/apt.15701 and https://doi.org/10.1111/apt.15759.

摘要

本文与 King 等人的文章以及 Benson-Pope 和 Greary 的文章相关。若要查看这些文章，请访问 https://doi.org/10.1111/apt.15701 和 https://doi.org/10.1111/apt.15759。